Impact of a Nutritional Supplement on the Recovery of the Nutritional Status of Patients With Spontaneous Hip Fracture

NCT ID: NCT04183075

Last Updated: 2020-09-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

82 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-09-30

Study Completion Date

2021-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Multicenter, prospective, randomized, double-blind, interventional study with a nutritional supplement against placebo in a cohort of patients hospitalized for hip fracture.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Hip fracture is a very prevalent pathology in the elderly population. It is estimated that 35-40% of people over 65 suffer a drop per year, and above 75 years this percentage is even higher, with hip fractures being one of the most serious consequences.With regard to malnutrition, the investigators know that aging carries an increased risk of suffering from decreased appetite and intake and changes in body composition. According to different series, the percentage of malnutrition in patients with hip fracture ranges from 13% to 60%. According to the hospital protocols in Spain in elderly people with spontaneous hip fracture, it is important to perform a nutritional screening during the first 24-48 hours of admission, to evaluate their nutritional status and apply a dietary treatment.

The IRENE study aims to determine whether phase angle and reactance, measured by electrical bioimpedance by vector analysis (BIVA) are related to functional recovery in patients with hip fracture.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Fractures Malnutrition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

FontActiv Superprotein/Hypercaloric Fiber

Full Nutritional Supplement

Group Type EXPERIMENTAL

FontActiv Superprotein/Hypercaloric Fiber

Intervention Type DIETARY_SUPPLEMENT

The product under study has a liquid presentation, in 200 ml bottles, ready to take

Carbohydrates and C Vitamin

Nutritional Supplement

Group Type ACTIVE_COMPARATOR

Carbohydrates and C Vitamin

Intervention Type DIETARY_SUPPLEMENT

The control product will be prepared with equal presentation and taste as similar as possible tan study product

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

FontActiv Superprotein/Hypercaloric Fiber

The product under study has a liquid presentation, in 200 ml bottles, ready to take

Intervention Type DIETARY_SUPPLEMENT

Carbohydrates and C Vitamin

The control product will be prepared with equal presentation and taste as similar as possible tan study product

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients over 65 years old.
* Patients admitted to hospital by spontaneous hip fracture and requiring surgery.
* Patients who after hip intervention are included in rehabilitation protocols with outpatient rehabilitation plan.
* Patients who agree to participate by signing informed consent or their regular caregivers grant consent.

Exclusion Criteria

* Patients who have a hip fracture from high-impact trauma or secondary to bone pathology (such as neoplasm).
* Patients with concomitant diseases such as severe hepatic impairment, severe renal impairment, insulin-dependent diabetes melitus and decompensated diabetes mellitus.
* Patients who require clinical stabilization before surgery beyond 72 hours.
* Patients receiving emergency surgery.
* Patients with previous prostheses.
* Patients with pacemakers.
* Patients who are not likely to complete the follow-up.
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Laboratorios Ordesa

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jose Manuel Garcia Almeida

Role: PRINCIPAL_INVESTIGATOR

Hospital Clínico de Málaga

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Clínico de Málaga

Málaga, Andalusia, Spain

Site Status

Hospital Virgen del Rocío

Seville, Andalusia, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Roser De Castellar, MD

Role: CONTACT

+34 902105243

Sandra Vidal, PhD

Role: CONTACT

+34 935 516 072

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jose Manuel Garcia Almeida

Role: primary

951 03 20 00

Pedro Pablo Garcia Luna

Role: primary

955 01 20 00

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRENE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.